GFA
JAZZ icon

Godfrey Financial Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

Godfrey Financial Associates’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45K Hold
6
– – ﹤0.01% 739
2026
Q1 		$1.13K Hold
6
– – ﹤0.01% 757
2025
Q4 		$1.02K Buy
+6
New +$920 ﹤0.01% 746

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Godfrey Financial Associates's JAZZ Position: Q2 2026 in Review

Godfrey Financial Associates held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 6 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #739.

Godfrey Financial Associates first reported a position in JAZZ in Q4 2025 and has held it in 3 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Godfrey Financial Associates held 6 shares of Jazz Pharmaceuticals worth $1.45K as of Q2 2026.
  • Godfrey Financial Associates left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Godfrey Financial Associates's portfolio in Q2 2026, its #739 holding.
  • Godfrey Financial Associates first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Godfrey Financial Associates's 13F filing for Q2 2026, filed 11 Aug 2026.